Gara Jalqabaatti › Liposarcoma
Qorannoo klinikaalii Liposarcoma Ameerikaa Keessatti hirmaatuu
Qorannoo 17 Liposarcoma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 10
- Boston, MAQorannoo 7
- St. Louis, MOQorannoo 5
- Queens, NYQorannoo 5
- Chicago, ILQorannoo 5
- New York City, NYQorannoo 5
- Edison, NJQorannoo 4
- Atlanta, GAQorannoo 4
- Seattle, WAQorannoo 3
- Richmond, VAQorannoo 3
- Phoenix, AZQorannoo 3
- San Diego, CAQorannoo 3
- Louisville, KYQorannoo 3
- Gainesville, FLQorannoo 3
- Nashville, TNQorannoo 3
- Miami, FLQorannoo 3
- Tampa, FLQorannoo 3
- Columbus, OHQorannoo 3
- Pittsburgh, PAQorannoo 3
- Rochester, MNQorannoo 3
- Aurora, COQorannoo 3
- Greenburgh, NYQorannoo 3
- New Rochelle, NYQorannoo 3
Naannoon
- ArizonaQorannoo 3
- CaliforniaQorannoo 6
- ColoradoQorannoo 3
- ConnecticutQorannoo 3
- FloridaQorannoo 4
- GeorgiaQorannoo 4
- IllinoisQorannoo 5
- KentuckyQorannoo 3
- MassachusettsQorannoo 7
- MichiganQorannoo 4
- MinnesotaQorannoo 3
- MissouriQorannoo 5
- New JerseyQorannoo 5
- New YorkQorannoo 6
- OhioQorannoo 6
- PennsylvaniaQorannoo 4
- TennesseeQorannoo 4
- TexasQorannoo 11
- VirginiaQorannoo 5
- WashingtonQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06422806Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06498648A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06881992A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06025747A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06843967Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT04031677Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06578624Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT05711615Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 30 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06541262STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT06975293Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT04715191NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 30 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06239272A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07089992Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ado-2026 · NCT07377747A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT06789172Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 26 · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT07148050Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 21 · Saalaa hunda · Haaromfame 03-Sad-2025 · NCT06198296Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.